403 related articles for article (PubMed ID: 18056176)
1. A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer.
Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA
Clin Cancer Res; 2007 Dec; 13(23):7003-11. PubMed ID: 18056176
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study.
van Oort IM; Tomita K; van Bokhoven A; Bussemakers MJ; Kiemeney LA; Karthaus HF; Witjes JA; Schalken JA
Prostate; 2007 Sep; 67(13):1432-8. PubMed ID: 17639504
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer.
Stefansson IM; Salvesen HB; Akslen LA
J Clin Oncol; 2004 Apr; 22(7):1242-52. PubMed ID: 15051772
[TBL] [Abstract][Full Text] [Related]
4. FOXC2 expression and epithelial-mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer.
Børretzen A; Gravdal K; Haukaas SA; Beisland C; Akslen LA; Halvorsen OJ
J Pathol Clin Res; 2019 Oct; 5(4):272-286. PubMed ID: 31464093
[TBL] [Abstract][Full Text] [Related]
5. N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion withStromal cells.
Tran NL; Nagle RB; Cress AE; Heimark RL
Am J Pathol; 1999 Sep; 155(3):787-98. PubMed ID: 10487836
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas.
Kallakury BV; Sheehan CE; Winn-Deen E; Oliver J; Fisher HA; Kaufman RP; Ross JS
Cancer; 2001 Dec; 92(11):2786-95. PubMed ID: 11753952
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer.
Lu Q; Dobbs LJ; Gregory CW; Lanford GW; Revelo MP; Shappell S; Chen YH
Hum Pathol; 2005 Oct; 36(10):1037-48. PubMed ID: 16226102
[TBL] [Abstract][Full Text] [Related]
8. Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease.
Bellovin DI; Bates RC; Muzikansky A; Rimm DL; Mercurio AM
Cancer Res; 2005 Dec; 65(23):10938-45. PubMed ID: 16322241
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.
Shimazui T; Schalken JA; Giroldi LA; Jansen CF; Akaza H; Koiso K; Debruyne FM; Bringuier PP
Cancer Res; 1996 Sep; 56(18):4154-8. PubMed ID: 8797585
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas.
Zhai B; Yan HX; Liu SQ; Chen L; Wu MC; Wang HY
World J Gastroenterol; 2008 Oct; 14(37):5665-73. PubMed ID: 18837082
[TBL] [Abstract][Full Text] [Related]
11. E- and N-cadherin differ with respect to their associated p120ctn isoforms and their ability to suppress invasive growth in pancreatic cancer cells.
Seidel B; Braeg S; Adler G; Wedlich D; Menke A
Oncogene; 2004 Jul; 23(32):5532-42. PubMed ID: 15107817
[TBL] [Abstract][Full Text] [Related]
12. Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas.
Kallakury BV; Sheehan CE; Ross JS
Hum Pathol; 2001 Aug; 32(8):849-55. PubMed ID: 11521230
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Twist-1, E-cadherin and EZH2 in Prostate Cancer: An Immunohistochemical Study.
Abdelrahman AE; Arafa SA; Ahmed RA
Turk Patoloji Derg; 2017; 1(1):198-210. PubMed ID: 28832071
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of p120-catenin, E-cadherin, and small GTPases is significantly associated with malignant phenotype of human lung cancer.
Liu Y; Wang Y; Zhang Y; Miao Y; Zhao Y; Zhang PX; Jiang GY; Zhang JY; Han Y; Lin XY; Yang LH; Li QC; Zhao C; Wang EH
Lung Cancer; 2009 Mar; 63(3):375-82. PubMed ID: 19162367
[TBL] [Abstract][Full Text] [Related]
15. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer.
Bremnes RM; Veve R; Gabrielson E; Hirsch FR; Baron A; Bemis L; Gemmill RM; Drabkin HA; Franklin WA
J Clin Oncol; 2002 May; 20(10):2417-28. PubMed ID: 12011119
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters.
Zhai B; Yan HX; Liu SQ; Chen L; Wu MC; Wang HY
World J Gastroenterol; 2008 Jun; 14(23):3739-44. PubMed ID: 18595142
[TBL] [Abstract][Full Text] [Related]
17. [Epithelial cadherins and associated molecules in invasive lobular breast cancer].
Brilliant YM; Brilliant AA; Sazonov SV
Arkh Patol; 2017; 79(1):12-18. PubMed ID: 28295003
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung.
Prudkin L; Liu DD; Ozburn NC; Sun M; Behrens C; Tang X; Brown KC; Bekele BN; Moran C; Wistuba II
Mod Pathol; 2009 May; 22(5):668-78. PubMed ID: 19270647
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic Study of Gleason Pattern 5 Prostatic Adenocarcinoma With "Single-cell" Growth Reveals 2 Distinct Types, One With "Plasmacytoid" Features.
Nguyen JK; Chen YY; Magi-Galluzzi C; McKenney JK
Am J Surg Pathol; 2020 Dec; 44(12):1635-1642. PubMed ID: 32991340
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
Murali AK; Norris JS
J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
